TREM2 agonist-5
TREM2 agonist-5 is the microglial lipid-sensing receptor (TREM2) agonist with a Kd of 71.36 μM. TREM2 agonist-5 is a racemic structural analog of the TREM2 agonist VG-3927 and exhibits superior microglial phagocytosis and activates TREM2 signaling in HEK293-hTREM2/DAP12 cells. TREM2 agonist-5 displays a superior in vitro pharmacokinetic profile to VG-3927. TREM2 agonist-5 can used for the study of Alzheimer’s disease[1].
Product Specifications
UNSPSC
12352005
Target
TREM receptor
Related Pathways
Immunology/Inflammation
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Purity
99.75
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CN1N=CC(C2C=C(C3=NC(C4=CC=C(Cl)C=C4F)=C(N=C(C)C(C)=N5)C5=C3)CCO2)=C1
Molecular Formula
C24H21ClFN5O
Molecular Weight
449.91
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
TREM-2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
(R)-3-(Benzylthio)-2-((tert-butoxycarbonyl)amino)propanoic acid